Author

M. A. Carlock

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 4 Organism:human· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

T. Ross· 4 shared B. Vitrinel· 2 shared C. Vogel· 2 shared H. Choi· 2 shared J. Rendleman· 2 shared M. Pressler· 2 shared S. Maity· 2 shared S. Pushalkar· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

T. Ross

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Differential cross-reactivity to the influenza B virus haemagglutinin underpins lineage-specific susceptibility between birth cohorts

P. Edler, L. S. U. Schwab, M. Aban, M. Wille, N. Spirason, Y.-M. Deng, M. A. Carlock, T. Ross, J. A. Juno, S. Rockman, A. K. Wheatley, S. J. Kent, I. Barr, D. J. Price, M. Koutsakos

The paper shows that early life exposure to influenza B virus influences cross-reactivity and susceptibility to future isolates, explaining lineage-specific infection patterns across birth cohorts.

bioRxiv · Aug 25, 2023 · PreprintImmunology

Complex changes in serum protein levels in COVID-19 convalescents

S. Pushalkar, S. Wu, S. Maity, M. Pressler, J. Rendleman, L. Y. Jeffrey, B. Vitrinel, M. A. Carlock, T. Ross, H. Choi, C. Vogel

This study identifies changes in serum protein levels in COVID-19 convalescents compared to healthy controls, revealing both similarities and differences with acute phase changes.

bioRxiv · Oct 26, 2022Immunology

Proteomic signatures of the serological response to flu vaccination in a large human cohort study

S. Wu, S. Pushalkar, S. Maity, M. Pressler, J. Rendleman, B. Vitrinel, M. A. Carlock, T. Ross, H. Choi, C. Vogel

The paper identifies proteomic signatures associated with seroconversion after flu vaccination in a human cohort, revealing links between protein levels and immune response factors.

bioRxiv · Sep 6, 2022 · PreprintImmunology

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

L. Li, Y. Honda-Okubo, Y. Huang, H. Jang, M. A. Carlock, J. Baldwin, S. Piplani, A. G. Bebin-Blackwell, D. Forgacs, K. Sakamoto, A. Stella, S. Turville, T. Chataway, A. Colella, J. Triccas, , N. Petrovsky

This study develops a recombinant SARS-CoV-2 spike protein vaccine, Covax-19, formulated with Advax-SM adjuvant, showing protection against COVID-19 in mice and ferrets.

bioRxiv · Jul 3, 2021Immunology